University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Twelve months after two 16 mg doses of the drug, called CYB003, seven patients saw their scores improve on the ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help ...

Fampridine, used for improving walking in multiple sclerosis, may also enhance working memory in individuals with schizophrenia or depression.

Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month ...

Beta blockers are go-to meds for many people who've survived a heart attack, but might not be needed for patients whose ...

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted ...

The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...

We could see that some of these patients appear to be more at risk of depression. If the drug doesn’t make a difference to their heart, then they are taking it unnecessarily and at risk of becoming ...

We could see that some of these patients appear to be more at risk of depression. If the drug doesn't make a difference to their heart, then they are taking it unnecessarily and at risk of becoming ...

In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for ...